SLC5A2 and hydrops fetalis: Second, progression of HF stage, reflected by recurrent and increasingly frequent hospitalizations, is tightly linked to prognosis; therefore, interrupting this trajectory early with SGLT2 inhibition can translate into a rapid reduction in hard events within 30–60 days, even if the full extent of quality-of-life recovery is captured later.